Mercedes
Salgado Fernández
![Foto de Mercedes](/img/nophoto.png)
![Foto de Complexo Hospitalario Universitario de Santiago](/img/noimage_org.png)
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (10)
2022
-
Venous Thromboembolism In Cancer Patients: “From Evidence to Care”
Clinical and Applied Thrombosis/Hemostasis, Vol. 28
2021
2020
-
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359
-
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial
Clinical and Translational Oncology, Vol. 22, Núm. 4, pp. 495-502
2018
-
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)
Oncologist, Vol. 23, Núm. 11, pp. 1271-e128
2015
-
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
Cancer Chemotherapy and Pharmacology, Vol. 76, Núm. 4, pp. 731-737
2010
-
A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
British Journal of Cancer, Vol. 103, Núm. 10, pp. 1536-1541
-
Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery
Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 3, pp. 567-573
-
Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy
Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 843-848